Free press releases distribution network?

More news: Health/Surgery
Agency / Source: ApaTech™ / ApaTech Ltd

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



ApaTech's Actifuse™ Shows Promising Results in Spinal Fusion Surgery - Philadelphia personal injury lawyer Roberta Pichini was recently elected Vice President of the International Academy of Trial Lawyers - ApaTech.com
ApaTech's Actifuse™ Shows Promising Results in Spinal Fusion Surgery

 

PRZOOM - /newswire/ - Elstree, Hertfordshire, United Kingdom, 2009/04/30 - Philadelphia personal injury lawyer Roberta Pichini was recently elected Vice President of the International Academy of Trial Lawyers - ApaTech.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health/Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

ApaTech has presented new clinical data for its unique synthetic bone graft, Actifuse, suggesting that it can provide a preferable alternative to the current ‘gold standard’ therapy, Iliac Crest Bone Graft (ICBG), in the treatment of patients with degenerative lumbar spine disease. ApaTech is a world leader in applying the science of silicon to bone graft technology.

Two new studies presented today at the North American Spine Society (NASS) Spring Break Meeting have shown that Actifuse has the potential to be as clinically effective as ICBG, without the problems associated with the latter.

The first study involved 38 patients with a diagnosis of lumbar stenosis, followed up two years after treatment with Actifuse as part of a standard lumbar fusion procedure. Fusion rates were graded at two years in excess of 81 percent. Results also showed a 68 percent decrease in pain experienced pre-operatively, as measured by the Visual Analogue Scale (VAS) (8.0 pre-operatively to 2.6 at two years), with 95 percent of patients reporting satisfaction levels that were good or excellent. There were no incidences of infection, bone graft complications or instrumentation failures.

The authors concluded that that both clinical results and fusion rates were comparable to those routinely achieved with ICBG, without any adverse effects.

The second study involved 69 patients with degenerative lumbar spine disease, of which 45 percent had two levels fused, and 41 percent were fused at three or more levels. All patients underwent a standard posterolateral spinal fusion using Actifuse. 81 percent of patients had radiographic evidence of bilateral bridging bone one year after surgery. 57 percent of patients reported relief from back pain, and 67 percent reported relief of leg pain. The authors concluded that Actifuse is an excellent alternative to ICBG for posterolateral spinal fusion in patients requiring surgical treatment for degenerative disease of the lumbar spine.

“These data provide further evidence that Actifuse is an excellent alternative to ICBG for physicians and patients offering comparable efficacy to ICBG without the need to take bone from the patient’s own skeleton” commented Brad G. Prybis, MD, Carrollton Orthopaedic Clinic, Carrollton, Georgia.

“These results for Actifuse are very exciting. We are proud to provide a new option for physicians in the treatment of degenerative lumbar spine disease” said ApaTech CEO Simon Cartmell. “These data further demonstrate ApaTech’s leadership in the science of silicon and the biostimulative effects of Actifuse.”

For further Information, please contact:
Fleishman-Hillard, TBC

About Actifuse™
The unique silicate substituted calcium phosphate chemistry of Actifuse™ is a significant advance in synthetic bone graft technology and provides surgeons with a safe and effective alternative to both autograft and allograft. Actifuse™ accelerates the formation of bone and improves the subsequent organisation and strength of the graft/host bone composite structure. Unlike traditional calcium phosphate based or other silicon containing products, Actifuse™ is steadily and predictably remodelled by the host biology over time, ensuring that sufficient conductive scaffold remains for the duration of new bone growth and its subsequent maturation.

Actifuse™ is available as a range of granule and microgranule formulations, as an Advanced Bone matriX; Actifuse™ ABX, in a standard applicator as a formable graft material: Actifuse™ Shape and in an EasyPrep granule applicator.

About ApaTech
ApaTech (apatech.com) specializes in producing synthetic bone repair material. It has operations in London, England, Foxborough, USA, and Berlin, Germany, and is a world leader in bone graft technologies, selling its products in 21 countries around the world.

The Company has developed a novel, silicate substituted calcium phosphate bone graft material, Actifuse, which underpins the Company’s leadership in applying the science of silicon to bone graft technologies. The Company believes that Actifuse™ is the first of a new class of synthetic bone graft materials that truly combine osteoconductive and biostimulative properties to accelerate bone formation and healing.

ApaTech is backed by international investors, 3i and Healthcor and was recognized as Britain’s fastest growing medical technology company in both the 2007 and 2008 Sunday Times Fast Track 100 fastest growing private companies review. ApaTech also won the 2009 Frost & Sullivan Award for Device Biologics Company of the Year recognizing the company’s position as a world leader in the orthobiologics market.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health/Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: ApaTech™ / ApaTech Ltd

 
 

Availability: All Metropolitan Area

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Health/Surgery articles,
CATCH Visitors via Your Competitors Announcements!


ApaTech's Actifuse™ Shows Promising Results in Spinal Fusion Surgery

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: Simon Cartmell - ApaTech.com 
+44(0)20 8731 4640 simon.cartmell[.]apatech.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any ApaTech™ / ApaTech Ltd securities in any jurisdiction including any other companies listed or named in this release.

Health/Surgery via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From ApaTech™ / ApaTech Ltd / Company Profile


Read Health/Surgery Most Recent Related Press Releases:

GE Healthcare Expands Digital Maternal-Infant Care Offerings with Acquisition of Monica Healthcare
Next-generation Natural Materials to Replace Traditional Synthetic Materials in Personal Care Products Finds Frost & Sullivan
Digital Innovation-driven Diagnostic Advances Transform Smart Healthcare Finds Frost & Sullivan
Hospitals’ Outsourcing of Sterile Processing Expand Opportunities for Third Party Service Providers in the US & Western Europe Finds Frost & Sullivan
Emerging Cardiac Therapies Catalysed by Innovative Product and Next-generation Technology Finds Frost & Sullivan
Austrian Centre of Industrial Biotechnology and GE Healthcare Establish A Cell Line Engineering Collaboration
Sequencing Platform Providers Aim to Develop Tests for Infectious Diseases to Expand Market Opportunity Finds Frost & Sullivan
Arcadia Wins Top Honors from Frost & Sullivan for its Next-generation Clinical and Claims Analytics Platform, Arcadia Analytics
Vendors Favour Platform Monitoring as Novel Service Models Disrupt APAC Home Health Monitoring Market Finds Frost & Sullivan
Leader Biomedical and Urogyn Collaborate to Bring Innovative New Procedure Urolastic™ to India

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  JobsWare.com

Visit  La Bella Bakery Artisan Bakery Arizona

Visit  BizJobs.com







 
  ©2017 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today